Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Cytogenetic analysis and Comet assay in detection of genome damage in medical personell occupationally exposed to antineoplastic drugs (CROSBI ID 467433)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa

Kopjar, Nevenka ; Garaj-Vrhovac, Verica ; Želježić, Davor Cytogenetic analysis and Comet assay in detection of genome damage in medical personell occupationally exposed to antineoplastic drugs // Abstracts of the 13th International Chromosome Conference ; u: Cytogenetics and Cell Genetics 81 (1998) (2) 91-168 / Olmo. Ettore (ur.). 1998

Podaci o odgovornosti

Kopjar, Nevenka ; Garaj-Vrhovac, Verica ; Želježić, Davor

engleski

Cytogenetic analysis and Comet assay in detection of genome damage in medical personell occupationally exposed to antineoplastic drugs

In the present study, the method of cytogenetic analysis of peripheral blood lymphocytes and Comet assay (single cell gell electrophoresis) were used to investigate medical personell employed in application of different antineoplastic drugs and control individuals. All subjects were previously interwieved to document a history of exposure to ionizing and nonionizing radiation, chemical exposure, viral infection or special long-term medications. The chromosome aberration analysis was performed on peripheral lymphocytes cultivated in vitro for 48h. The Comet assay was performed on the same blood samples according as described by Singh et al. (1994). The exposed group showed an increased number of chromatid and chromosome breaks compared to control. The results of the Comet assay indicate that lymphocytes from exposed subjects have a greater migration of DNA (measured with the comet assay as tail length, tail moment and tail % DNA) then control lymphocytes. Results obtained show that antineoplastic drugs caused damages of DNA which could be easily detected with both methods. As a simple, rapid and sensitive method, Comet assay was more helpful in detection of genome damage and might therefore be recommended as a standard biomonitoring tool.

antineoplastic drugs; comet assay; biomonitoring

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

1998.

objavljeno

Podaci o matičnoj publikaciji

Abstracts of the 13th International Chromosome Conference ; u: Cytogenetics and Cell Genetics 81 (1998) (2) 91-168

Olmo. Ettore

Podaci o skupu

International Chromosome Conference (13 ; 1998)

poster

08.09.1998-12.09.1998

Ancona, Italija

Povezanost rada

Javno zdravstvo i zdravstvena zaštita